Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anne M Ryschon"'
Autor:
Jan B Pietzsch, Benjamin P Geisler, Abigail M Garner, Anne M Ryschon, William A Gray, Masahiko Fujihara, Peter A Schneider
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 14, Iss 1 (2024)
Aim: Percutaneous transluminal angioplasty (PTA) for peripheral artery disease (PAD) commonly leads to dissections which are associated with higher target lesion revascularization (TLR) rates. Clinical and economic consequences of dissection manage
Externí odkaz:
https://doaj.org/article/31cab84838b84a60bd17d433dd3b49c1
Autor:
Oriol Rodríguez-Leor, Anne M. Ryschon, Khoa N. Cao, Fernando Jaén-Águila, Tamara García-Camarero, Carlos Mansilla-Morales, Michael Kolovetsios, María Álvarez-Orozco, José Antonio García-Donaire, Jan B. Pietzsch
Publikováno v:
REC: Interventional Cardiology, Vol 6, Iss 4, Pp 305-312 (2024)
RESUMEN Introducción y objetivos: La denervación renal (DNR) por radiofrecuencia (RF) es una alternativa terapéutica eficaz y segura en pacientes con hipertensión no controlada. Este estudio evalúa el coste-efectividad de esta terapia en España
Externí odkaz:
https://doaj.org/article/eaec415fa46046d08a811b862bc35a12
Autor:
David E. Kandzari, MD, Khoa N. Cao, MBBS, MPH, MS, Anne M. Ryschon, MA, Andrew S.P. Sharp, MBChB, MD, Jan B. Pietzsch, PhD
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 3, Iss 10, Pp 102234- (2024)
Background: Catheter-based radiofrequency renal denervation (RF RDN) has recently been approved as an adjunctive treatment for hypertensive patients without adequate blood pressure control. This study assessed the cost-effectiveness of RF RDN in the
Externí odkaz:
https://doaj.org/article/4e9cfb6260764805ab1131e23e0397dd
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 2133-2146 (2023)
Abstract Introduction Tonic motor activation (TOMAC) therapy is a novel non-pharmacologic treatment approach for patients suffering from medication-refractory restless legs syndrome (RLS). The objective of this study was to explore the potential cost
Externí odkaz:
https://doaj.org/article/beb009742e914f5eb010511c294255a2
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 12, Pp 1502-1512 (2024)
ABSTRACT Radiofrequency renal denervation (RF RDN) is a novel therapy for uncontrolled hypertension. In the recent sham‐controlled SPYRAL HTN‐ON MED study, office‐based systolic blood pressure (oSBP) and nighttime BP were reduced significantly.
Externí odkaz:
https://doaj.org/article/36c2458ae8654419816f25b4a715fb49